Repare Therapeutics Inc. 8-K Filing: Key Updates for Investors (Jan 9, 2025)

Based on the provided XML section from the financial report, here are the key insights and information extracted:

1. Entity Information:

• Company Name: Repare Therapeutics Inc.
• CIK (Central Index Key): 0001808158
• SEC File Number: 001-39335
• Address: 7171 Frederick-Banting, Building 2 Suite 270, St-Laurent, QC, CA H4S 1Z9
• Phone Number: 857-412-7018

2. Report Type:

• Filing Type: 8-K (a current report to announce major events that shareholders should know about)

3. Filing Date:

• Date of Report: January 9, 2025

4. Security Information:

• Type of Security: Common shares, no par value
• Stock Symbol: RPTX
• Exchange: NASDAQ

5. Period Context:

• Reporting Period: The report covers a specific date, January 9, 2025.

Key Insights:

• The filing is for an 8-K, indicating a significant event or change that may impact investors.
• The company is publicly traded on NASDAQ under the ticker symbol RPTX, which may be relevant for investors tracking stock performance.
• The report provides essential contact and identification details for the company, useful for further inquiries or research.

Additional Notes:

• No specific financial data or event details are included in this section, so further analysis would require reviewing the full content of the 8-K filing to understand the nature of the report and its implications for stakeholders.